Report cover image

Quantum Cryptography Market Size, Share, Trends, & Industry Analysis Report By Offering (Solutions and Services), By Security Type, By Vertical, and By Region – Market Forecast, 2025–2034

Published May 01, 2025
Length 114 Pages
SKU # PLRS20199159

Description

The global quantum cryptography market size is expected to reach USD 18,032.35 Million by 2034, according to a new study by Polaris Market Research. The report “Quantum Cryptography Market Size, Share, Trends, Industry Analysis Report: By Offering (Solutions and Services), Security Type, Vertical, and Region– Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Quantum cryptography, also known as quantum encryption, is a field that utilizes the principles of quantum mechanics to achieve secure communication. Instead of relying on the computational difficulty of mathematical problems, as in classical cryptography, quantum cryptography harnesses the fundamental laws of physics, such as the Heisenberg uncertainty principle and quantum superposition, to encode and transmit information. A primary application of this technology is Quantum Key Distribution (QKD), which enables two parties to establish a shared secret key with the theoretical guarantee that any attempt by a third party to intercept the key will be detected. This inherent security against eavesdropping is a defining characteristic of quantum cryptography.

The quantum cryptography market is currently experiencing significant interest and growth, driven by the increasing need for robust security solutions in an era of advancing computational power, including the looming threat of quantum computers that could potentially break existing encryption methods. The market encompasses various offerings, including QKD systems, quantum random number generators (QRNGs), and post-quantum cryptographic algorithms. Key market drivers include the rising frequency and sophistication of cyberattacks, growing government and defense investments in secure communication, and the increasing adoption of cloud-based services. While still in a relatively early stage of commercialization compared to classical cryptography, quantum cryptography holds immense potential for securing sensitive data across sectors like finance, healthcare, and government, shaping the future landscape of secure communication.

Quantum Cryptography Market Report Highlights:

By offering, the solutions subsegment currently holds the highest market share due to the significant demand for quantum key distribution (QKD) systems and related hardware and software vital for securing communication infrastructure against evolving cyber threats.

By security type, the network security subsegment currently holds the largest market share as the initial focus of quantum cryptography has been on securing communication networks against eavesdropping using technologies like quantum key distribution (QKD).

North America quantum cryptography market held the largest share in 2024 driven by the presence of leading technology companies, substantial investments in research and development.

The Asia Pacific quantum cryptography market is projected to exhibit the highest growth rate over the forecast period driven by increasing government investments in quantum research and development across major Asian countries.

Some of the major players in the quantum cryptography market include ID Quantique, Quantum Xchange, Toshiba Corporation, MagiQ Technologies, Inc., QuintessenceLabs Pty Ltd, Crypta Labs Ltd, Qubitekk, Inc., Post-Quantum, PQShield, QNu Labs, KETS Quantum Security, and ISARA Corporation.

Polaris Market Research has segmented the Quantum Cryptography market report based on offering, security type, vertical, and region:

By Offering Outlook (Revenue – USD Million, 2020–2034)

Solutions

Services

By Security Type Outlook (Revenue – USD Million, 2020–2034)

Network Security

Application Security

By Vertical Outlook (Revenue – USD Million, 2020–2034)

Government

Defense

BFSI

Health Care

Retail & eCommerce

By Regional Outlook (Revenue – USD Million, 2020–2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia-Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia-Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

114 Pages
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Source
3.2.1. Primary Source
3.2.2. Secondary Source
4. Global Proteomics Market Insights
4.1. Proteomics Market – Market Snapshot
4.2. Proteomics Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing Focus on Personalized Medicine
4.2.1.2. Advancements in Drug Discovery and Development
4.2.2. Restraints and Challenges
4.2.2.1. High cost of proteomics instruments and reagents
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Proteomics Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Proteomics Market, by Product Type
5.1. Key Findings
5.2. Introduction
5.2.1. Global Proteomics Market, by Product Type, 2020–2034 (USD Billion)
5.3. Instruments
5.3.1. Global Proteomics Market, by Instruments, by Region, 2020–2034 (USD Billion)
5.3.2. Protein Microarray
5.3.3. Spectrometry
5.3.3.1. Mass Spectrometry
5.3.3.2. NMR Spectroscopy
5.3.4. Chromatography
5.3.4.1. HPLC Systems
5.3.4.2. Ion Chromatography
5.3.4.3. Affinity Chromatography
5.3.4.4. Supercritical Fluid Chromatography
5.3.5. Electrophoresis
5.3.5.1. Gel Electrophoresis
5.3.5.2. Capillary Electrophoresis
5.3.6. Surface Plasmon Resonance
5.3.7. X-ray Crystallography
5.3.8. Protein Fractionation Systems
5.4. Reagents & Consumables
5.4.1. Global Proteomics Market, by Reagents & Consumables, by Region, 2020–2034 (USD Billion)
5.4.2. Microarray
5.4.3. Spectroscopy
5.4.4. X-ray Crystallography
5.4.5. Chromatography
5.4.6. Electrophoresis
5.4.7. Immunoassay
5.4.8. Protein Fractionation Reagents
5.5. Services
5.5.1. Global Proteomics Market, by Services, by Region, 2020–2034 (USD Billion)
6. Global Proteomics Market, by Application
6.1. Key Findings
6.2. Introduction
6.2.1. Global Proteomics Market, by Application, 2020–2034 (USD Billion)
6.3. Drug Discovery
6.3.1. Global Proteomics Market, by Drug Discovery, by Region, 2020–2034 (USD Billion)
6.4. Clinical Diagnosis
6.4.1. Global Proteomics Market, by Clinical Diagnosis, by Region, 2020–2034 (USD Billion)
6.5. Molecular Medicine
6.5.1. Global Proteomics Market, by Molecular Medicine, by Region, 2020–2034 (USD Billion)
6.6. Others
6.6.1. Global Proteomics Market, by Others, by Region, 2020–2034 (USD Billion)
7. Global Proteomics Market, by Technology
7.1. Key Findings
7.2. Introduction
7.2.1. Global Proteomics Market, by Technology, 2020–2034 (USD Billion)
7.3. Microarray Instruments
7.3.1. Global Proteomics Market, by Microarray Instruments, by Region, 2020–2034 (USD Billion)
7.4. X-Ray Crystallography
7.4.1. Global Proteomics Market, by X-Ray Crystallography, by Region, 2020–2034 (USD Billion)
7.5. Spectroscopy
7.5.1. Global Proteomics Market, by Spectroscopy, by Region, 2020–2034 (USD Billion)
7.6. Chromatography
7.6.1. Global Proteomics Market, by Chromatography, by Region, 2020–2034 (USD Billion)
7.7. Protein Fractionation Systems
7.7.1. Global Proteomics Market, by Protein Fractionation Systems, by Region, 2020–2034 (USD Billion)
7.8. Electrophoresis
7.8.1. Global Proteomics Market, by Electrophoresis, by Region, 2020–2034 (USD Billion)
7.9. Surface Plasma Resonance (SPR) Systems
7.9.1. Global Proteomics Market, by Surface Plasma Resonance (SPR) Systems, by Region, 2020–2034 (USD Billion)
8. Global Proteomics Market, by Geography
8.1. Key Findings
8.2. Introduction
8.2.1. Proteomics Market Assessment, By Geography, 2020–2034 (USD Billion)
8.3. Proteomics Market – North America
8.3.1. North America: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.3.2. North America: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.3.3. North America: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.3.4. Proteomics Market – U.S.
8.3.4.1. U.S.: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.3.4.2. U.S.: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.3.4.3. U.S.: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.3.5. Proteomics Market – Canada
8.3.5.1. Canada: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.3.5.2. Canada: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.3.5.3. Canada: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4. Proteomics Market – Europe
8.4.1. Europe: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.2. Europe: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.3. Europe: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.4. Proteomics Market – UK
8.4.4.1. UK: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.4.2. UK: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.4.3. UK: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.5. Proteomics Market – France
8.4.5.1. France: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.5.2. France: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.5.3. France: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.6. Proteomics Market – Germany
8.4.6.1. Germany: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.6.2. Germany: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.6.3. Germany: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.7. Proteomics Market – Italy
8.4.7.1. Italy: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.7.2. Italy: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.7.3. Italy: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.8. Proteomics Market – Spain
8.4.8.1. Spain: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.8.2. Spain: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.8.3. Spain: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.9. Proteomics Market – Netherlands
8.4.9.1. Netherlands: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.9.2. Netherlands: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.9.3. Netherlands: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.10. Proteomics Market – Russia
8.4.10.1. Russia: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.10.2. Russia: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.10.3. Russia: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.4.11. Proteomics Market – Rest of Europe
8.4.11.1. Rest of Europe: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.4.11.2. Rest of Europe: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.4.11.3. Rest of Europe: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5. Proteomics Market – Asia Pacific
8.5.1. Asia Pacific: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.2. Asia Pacific: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.3. Asia Pacific: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.4. Proteomics Market – China
8.5.4.1. China: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.4.2. China: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.4.3. China: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.5. Proteomics Market – India
8.5.5.1. India: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.5.2. India: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.5.3. India: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.6. Proteomics Market – Malaysia
8.5.6.1. Malaysia: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.6.2. Malaysia: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.6.3. Malaysia: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.7. Proteomics Market – Japan
8.5.7.1. Japan: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.7.2. Japan: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.7.3. Japan: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.8. Proteomics Market – Indonesia
8.5.8.1. Indonesia: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.8.2. Indonesia: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.8.3. Indonesia: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.9. Proteomics Market – South Korea
8.5.9.1. South Korea: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.9.2. South Korea: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.9.3. South Korea: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.10. Proteomics Market – Australia
8.5.10.1. Australia: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.10.2. Australia: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.10.3. Australia: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.5.11. Proteomics Market – Rest of Asia Pacific
8.5.11.1. Rest of Asia Pacific: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.5.11.2. Rest of Asia Pacific: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.5.11.3. Rest of Asia Pacific: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6. Proteomics Market – Middle East & Africa
8.6.1. Middle East & Africa: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.2. Middle East & Africa: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.3. Middle East & Africa: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6.4. Proteomics Market – Saudi Arabia
8.6.4.1. Saudi Arabia: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.4.2. Saudi Arabia: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.4.3. Saudi Arabia: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6.5. Proteomics Market – UAE
8.6.5.1. UAE: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.5.2. UAE: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.5.3. UAE: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6.6. Proteomics Market – Israel
8.6.6.1. Israel: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.6.2. Israel: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.6.3. Israel: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6.7. Proteomics Market – South Africa
8.6.7.1. South Africa: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.7.2. South Africa: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.7.3. South Africa: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.6.8. Proteomics Market – Rest of Middle East & Africa
8.6.8.1. Rest of Middle East & Africa: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.6.8.2. Rest of Middle East & Africa: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.6.8.3. Rest of Middle East & Africa: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.7. Proteomics Market – Latin America
8.7.1. Latin America: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.7.2. Latin America: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.7.3. Latin America: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.7.4. Proteomics Market – Mexico
8.7.4.1. Mexico: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.7.4.2. Mexico: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.7.4.3. Mexico: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.7.5. Proteomics Market – Brazil
8.7.5.1. Brazil: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.7.5.2. Brazil: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.7.5.3. Brazil: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.7.6. Proteomics Market – Argentina
8.7.6.1. Argentina: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.7.6.2. Argentina: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.7.6.3. Argentina: Proteomics Market, by Technology, 2020–2034 (USD Billion)
8.7.7. Proteomics Market – Rest of Latin America
8.7.7.1. Rest of Latin America: Proteomics Market, by Product Type, 2020–2034 (USD Billion)
8.7.7.2. Rest of Latin America: Proteomics Market, by Application, 2020–2034 (USD Billion)
8.7.7.3. Rest of Latin America: Proteomics Market, by Technology, 2020–2034 (USD Billion)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Agilent Technologies, Inc.
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Recent Development
10.2. Bio-Rad Laboratories, Inc
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Recent Development .
10.3. Bruker Corporation
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Recent Development
10.4. Danaher Corporation
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Recent Development
10.5. Merck KGaA
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Development
10.6. PerkinElmer, Inc.
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Development
10.7. QIAGEN N.V.
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Development
10.8. SCIEX
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Development
10.9. Thermo Fisher Scientific Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Development
10.10. Waters Corporation
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Development
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.